The latest report by IMARC Group, titled "Industrial Microbiology Market Report by Product (Equipment and Systems, Reaction Consumables, and Others), Test Type (Sterility Testing, Microbial Limits Testing, Bio-burden Testing, Water and Environmental Testing), End Use Industry (Food and Beverages, Pharmaceutical Biotechnology, Agricultural, Environmental, Cosmetic and Personal Care, and Others), and Region 2025-2033," finds that the global industrial microbiology market reached a value of USD 12.3 Billion in 2024. Industrial microbiology, also known as microbial biotechnology, is the process of using various microorganisms, such as naturally occurring organisms, laboratory-selected mutants, and genetically modified organisms (GMO), for the production of crucial substances, such as food products, antibiotics, enzymes, amino acids, vaccines, and fine chemicals. It assists in replacing non-biodegradable plastics, fossil fuels, and highly polluting chemical processes with biocompatible alternatives. Besides this, industrial microbiology finds extensive application in manufacturing alcohol and acetone across the globe.
Global Industrial Microbiology Market Trends:
The market is primarily driven by the expanding pharmaceutical industry. Industrial microbiology is used to manufacture vaccines, antibiotics, and steroids. It also aids in preventing microbial contamination of injectables, nasal solutions, drugs, eye drops, and inhalation products. In addition, the rising product adoption in the food and beverage (F&B) industry is to produce fermented food products and convert industrial food waste into value-added products. Besides this, industrial microbiology finds extensive applications in the oil and gas industry as it is not impacted by crude oil prices and does not require vast energy inputs. This, coupled with the rapid depletion of oil resources and increasing energy demands, is catalyzing the need for eco-friendly and cost-effective oil recovery technologies. Moreover, the increasing utilization of industrial microbiology in the cosmetics and personal care industry is anticipated to propel market growth in the coming years. Looking forward, IMARC Group expects the market to reach a value of USD 22.8 Billion by 2033, exhibiting a CAGR of 6.8% during the forecast period (2025-2033).
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product, Test Type, End Use Industry, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 3M Company, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Danaher Corporation, Eppendorf AG, QIAGEN, Sartorius AG, Merck KGaA and Thermo Fisher Scientific Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800